SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-23-072629
Filing Date
2023-08-31
Accepted
2023-08-31 09:15:39
Documents
122
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT f20f2023_alteritytherap.htm   iXBRL 20-F 2244218
2 CERTIFICATION f20f2023ex12-1_alterity.htm EX-12.1 10881
3 CERTIFICATION f20f2023ex12-2_alterity.htm EX-12.2 10415
4 CERTIFICATION f20f2023ex13-1_alterity.htm EX-13.1 4315
5 CERTIFICATION f20f2023ex13-2_alterity.htm EX-13.2 4378
6 CONSENT OF PRICEWATERHOUSECOOPERS f20f2023ex15-1_alterity.htm EX-15.1 1751
7 AUDITOR'S INDEPENDENCE DECLARATION f20f2023ex15-2_alterity.htm EX-15.2 647
8 GRAPHIC image_001.jpg GRAPHIC 71555
  Complete submission text file 0001213900-23-072629.txt   10670607

Data Files

Seq Description Document Type Size
9 XBRL SCHEMA FILE athe-20230630.xsd EX-101.SCH 156616
10 XBRL CALCULATION FILE athe-20230630_cal.xml EX-101.CAL 33576
11 XBRL DEFINITION FILE athe-20230630_def.xml EX-101.DEF 386807
12 XBRL LABEL FILE athe-20230630_lab.xml EX-101.LAB 841630
13 XBRL PRESENTATION FILE athe-20230630_pre.xml EX-101.PRE 407605
116 EXTRACTED XBRL INSTANCE DOCUMENT f20f2023_alteritytherap_htm.xml XML 2020970
Mailing Address LEVEL 3, 460 BOURKE STREET MELBOURNE C3 VIC 3000
Business Address LEVEL 3, 460 BOURKE STREET MELBOURNE C3 VIC 3000 61 3 9349 4906
ALTERITY THERAPEUTICS LTD (Filer) CIK: 0001131343 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 20-F | Act: 34 | File No.: 000-49843 | Film No.: 231227175
SIC: 2834 Pharmaceutical Preparations